During the past decade, Hopital De Haut Leveque; Hematologie Clinique conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital De Haut Leveque; Hematologie Clinique" #1 collaborator was "Pharmacyclics LLC." with 2 trials as a collaborator, "ClinAssess GmbH" with 1 trials as a collaborator, "GELARC Service de Pharmacovigilance, Pierre Benite" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Klinikum der Universitaet Muenchen, Grosshadern" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hopital De Haut Leveque; Hematologie Clinique" are "Chronic Lymphocytic Leukemia" (2 trials), "Mantle Cell Lymphoma" (2 trials), "Non-Hodgkin's Lymphoma" (2 trials), "Acute Myeloid Leukemia" (1 trials) and "B-cell Lymphoma" (1 trials). Many other conditions were trialed in "Hopital De Haut Leveque; Hematologie Clinique" in a lesser frequency.

Most popular intervention types in "Hopital De Haut Leveque; Hematologie Clinique" are "Drug" (14 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (6 trials), "Cyclophosphamide" (3 trials), "Obinutuzumab" (3 trials), "Bendamustine" (2 trials) and "Chlorambucil" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hopital De Haut Leveque; Hematologie Clinique" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Hopital De Haut Leveque; Hematologie Clinique". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 4 completed trials in Hopital De Haut Leveque; Hematologie Clinique, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital De Haut Leveque; Hematologie Clinique, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Hopital De Haut Leveque; Hematologie Clinique has several departments that took part in Clinical trials: "Hopital Du Haut-Leveque; Gastro-Enterologie" - 10 trials, "Groupe Hospitalier Sud Hopital Haut Leveque USN" - 7 trials, "Hopital Saint Andre; Département de Radiothérapie Et D'Oncologie Médicale" - 5 trials, "Service de Dermatologie - Hôpital Saint André" - 5 trials, "Service des maladies du sang - Hôpital Haut-Lévêque - avenue de magellan" - 5 trials, "Hopital Pellegrin; Departement Nephrologie" - 5 trials, "Hopital Pellegrin; Cmrr Aquitaine" - 5 trials, "Département d'Anesthésie-Réanimation II - Hôpital cardiologique - Groupe Hospitalier Sud, CHU de Bordeaux - 4, Av de Magellan" - 2 trials, "Pellegrin Hospital, Recovery Unit" - 2 trials, "CHU de Bordeaux - Service d'Immunologie et Immunogénétique" - 2 trials, "CMRR Hôpital Pellegrin, Bâtiment USN Tastet Girard" - 2 trials, "Unité Médicale Rétine Neuro-Ophtalmologie - Service d'Ophtalmologie - Hopital Pellegrin" - 2 trials